- Home
- NG vs QDEL Comparison
NG vs QDEL Comparison
Compare NG & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NG | QDEL |
|---|---|---|
| Founded | 1984 | 1979 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NG | QDEL |
|---|---|---|
| Price | $10.49 | $28.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | $10.17 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 2.5M | 950.8K |
| Earning Date | 01-22-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,714,400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.26 | $19.50 |
| 52 Week High | $11.29 | $46.24 |
Technical Indicators
Market Signals| Indicator | NG | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 57.29 | 42.25 |
| Support Level | $9.34 | $27.19 |
| Resistance Level | $11.29 | $35.58 |
| Average True Range (ATR) | 0.59 | 2.15 |
| MACD | 0.00 | -0.71 |
| Stochastic Oscillator | 58.65 | 15.27 |
Price Performance
Historical ComparisonAbout NG Novagold Resources Inc.
Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other presious metals.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.